Invesco India Pharma And Healthcare Fund Direct Growth

INF205KA1BX5 Invesco Asset Management (India) Pvt Ltd Equity Growth

Latest NAV

₹9.4100

+0.00% 1Y

as of 05 Oct 2026

Expense ratio

0.00%

AUM

₹0 Cr

Min SIP

₹100

Min lump sum

₹1,000

+0.00%

3Y (ann.)

+0.00%

5Y (ann.)

+0.00%

Launched

Sep 2026

Where the NAV sits & how risky it is

₹9.41

52-week range at 0%

₹9.41

Low 01 Oct 2026₹9.57

High 23 Sep 2026₹10.10

Risk level Very High

Low

Very high

NAV history

10 Sep 2026 Since inception 05 Oct 2026

Returns by period

-4.59%

+0.00%

3Y and 5Y returns are annualised.

Return calculator

Monthly investment

Time period yrs

Assumed yearly return

Top up SIP 10% a year

You invest

—

Est. gain

—

Est. value

—

Invested Gain

Invested Projected value min SIP ₹100

Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. This scheme is too new to have a track record for any of those windows, so the calculator starts on a neutral custom rate — change it to whatever you assume.

Where your money goes

No portfolio disclosure is available for this scheme yet.

About this scheme

To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.

Fund manager(s): Taher Badshah

Exit load: Exit load of 0.50%, if redeemed within 3 months.

Scheme snapshot

VR Rating

MS Rating

Plan

Growth

Type

DIRECT

Inception

07 Sep 2026

Lump-sum min